{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:23:37Z","timestamp":1792027417518,"version":"4.4.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.brachy.2016.04.005","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T22:13:59Z","timestamp":1464732839000},"page":"95-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review"],"prefix":"10.1016","volume":"16","author":[{"given":"Matthew M.","family":"Harkenrider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec M.","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaled M.","family":"Alektiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Gaffney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Klopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akila N.","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"William","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2016.04.005_bib1","unstructured":"What are the key statistics about endometrial cancer? Available at:\u00a0http:\/\/www.cancer.org\/cancer\/endometrialcancer\/detailedguide\/endometrial-uterine-cancer-key-statistics. Accessed June 28,\u00a02015."},{"key":"10.1016\/j.brachy.2016.04.005_bib2","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.brachy.2016.04.005_bib3","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2016.04.005_bib4","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2016.04.005_bib5","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2016.04.005_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1245\/s10434-015-4583-3","article-title":"Tumor size, an additional prognostic factor to include in low-risk endometrial cancer: Results of a French multicenter study","volume":"23","author":"Canlorbe","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ygyno.2013.10.023","article-title":"High-grade endometrial cancer: Revisiting the impact of tumor size and location on outcomes","volume":"132","author":"Doll","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ygyno.2004.08.019","article-title":"Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium","volume":"95","author":"Creasman","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib10","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1016\/j.ijrobp.2011.04.013","article-title":"Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma","volume":"81","author":"Creutzberg","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib11","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ijrobp.2005.03.007","article-title":"Postoperative radiotherapy for Stage 1 endometrial carcinoma: Long-term outcome of the randomized PORTEC trial with central pathology review","volume":"63","author":"Scholten","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib12","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0360-3016(01)01765-5","article-title":"The morbidity of treatment for patients with Stage I endometrial cancer: Results from a randomized trial","volume":"51","author":"Creutzberg","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib13","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1200\/JCO.2010.32.4590","article-title":"Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial","volume":"29","author":"Nout","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ygyno.2005.11.004","article-title":"Salvage treatment with high-dose-rate brachytherapy for isolated vaginal endometrial cancer recurrence","volume":"101","author":"Petignat","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0360-3016(90)90094-Z","article-title":"Postoperative vaginal irradiation with high dose rate afterloading technique in endometrial carcinoma stage I","volume":"18","author":"Sorbe","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib16","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/0360-3016(95)00097-I","article-title":"Postoperative vaginal cuff\u00a0irradiation using high dose rate remote afterloading: A phase\u00a0II clinical protocol","volume":"32","author":"Noyes","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF03039188","article-title":"The vaginal stump recurrence rate in endometrial carcinoma in relation to the target volume of postoperative HDR-afterloading brachytherapy","volume":"173","author":"Kloetzer","year":"1997","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.brachy.2016.04.005_bib18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0360-3016(97)00040-0","article-title":"Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: Report of a prospective trial","volume":"38","author":"Eltabbakh","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib19","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0360-3016(98)00292-2","article-title":"High-dose-rate brachytherapy alone post-hysterectomy for endometrial cancer","volume":"42","author":"MacLeod","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1006\/gyno.1998.5155","article-title":"Adjuvant vaginal high-dose-rate afterloading alone in endometrial carcinoma: Patterns of relapse and side effects following low-dose therapy","volume":"71","author":"Weiss","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/gyno.1999.5526","article-title":"Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy","volume":"75","author":"Chadha","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib22","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1525-1438.1999.99061.x","article-title":"Outpatient vaginal cuff brachytherapy for endometrial cancer","volume":"9","author":"Petereit","year":"1999","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2016.04.005_bib23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0360-3016(99)00427-7","article-title":"High-dose-rate postoperative vaginal cuff irradiation alone for stage IB and IC endometrial cancer","volume":"46","author":"Anderson","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib24","first-page":"235","article-title":"Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma","volume":"99","author":"Horowitz","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.brachy.2016.04.005_bib25","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0360-3016(02)02792-X","article-title":"Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer","volume":"53","author":"Alektiar","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib26","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.ygyno.2005.02.021","article-title":"Vaginal brachytherapy alone: An alternative to adjuvant whole pelvis radiation for early stage endometrial cancer","volume":"97","author":"Jolly","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijrobp.2004.09.054","article-title":"Intravaginal brachytherapy alone for intermediate-risk endometrial cancer","volume":"62","author":"Alektiar","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib28","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.ijrobp.2005.01.026","article-title":"Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer","volume":"62","author":"Solhjem","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib29","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1525-1438.2008.01198.x","article-title":"Vaginal high dose rate brachytherapy alone in patients with intermediate- to high-risk stage I endometrial carcinoma after radical surgery","volume":"18","author":"Atahan","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2016.04.005_bib30","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ygyno.2009.06.027","article-title":"Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation","volume":"116","author":"McCloskey","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib31","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/IGC.0b013e3182643ba0","article-title":"External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma: A prospective, randomized study\u2013quality-of-life analysis","volume":"22","author":"Sorbe","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2016.04.005_bib32","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijrobp.2011.12.010","article-title":"Clinical outcomes in international federation of gynecology and obstetrics stage IA endometrial cancer with myometrial invasion treated with or without postoperative vaginal brachytherapy","volume":"84","author":"Diavolitsis","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.5114\/jcb.2014.45031","article-title":"Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer","volume":"6","author":"Eldredge-Hindy","year":"2014","journal-title":"J\u00a0Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2016.04.005_bib34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.brachy.2015.02.196","article-title":"Adjuvant radiotherapy in Stage II endometrial carcinoma: Is brachytherapy alone sufficient for local control?","volume":"14","author":"Paydar","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.04.005_bib35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ygyno.2014.12.036","article-title":"The role of vaginal cuff brachytherapy in endometrial cancer","volume":"136","author":"Harkenrider","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0167-8140(89)90036-4","article-title":"Endometrial carcinoma: High dose-rate brachytherapy in combination with external irradiation; a multivariate analysis of relapses","volume":"16","author":"Lybeert","year":"1989","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib37","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0360-3016(94)90357-3","article-title":"Postoperative high dose-rate intravaginal brachytherapy combined with external irradiation for early stage endometrial cancer: A long-term follow-up","volume":"30","author":"Nori","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib38","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ygyno.2008.12.029","article-title":"Outcomes following surgery and adjuvant radiation in stage II endometrial adenocarcinoma","volume":"113","author":"Cannon","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5114\/jcb.2015.50877","article-title":"The impact of a vaginal brachytherapy boost to pelvic radiation in stage III endometrial cancer","volume":"7","author":"Huddleston","year":"2015","journal-title":"J\u00a0Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2016.04.005_bib40","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.ijrobp.2008.06.803","article-title":"A phase II study of intensity modulated radiation therapy (IMRT) to the pelvic for post-operative patients with endometrial carcinoma (RTOG 0418)","volume":"72","author":"Jhingran","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib41","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1002\/cncr.29337","article-title":"NRG Oncology\/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer","volume":"121","author":"Viswanathan","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2016.04.005_bib42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ygyno.2013.11.005","article-title":"Phase II trial of vaginal cuff brachytherapy followed by chemotherapy in early stage endometrial cancer patients with high-intermediate risk factors","volume":"132","author":"Landrum","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib43","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ygyno.2014.07.078","volume":"134","author":"McMeekin","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib44","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ygyno.2009.11.027","article-title":"A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: Toward improving individualized cancer care","volume":"116","author":"Abu-Rustum","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib45","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/j.ajog.2012.06.080","article-title":"A nomogram for predicting lymph node metastasis of presumed stage I and II endometrial cancer","volume":"207","author":"Bendifallah","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.brachy.2016.04.005_bib46","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ygyno.2013.06.037","article-title":"Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer","volume":"131","author":"AlHilli","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib47","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/IGC.0000000000000090","article-title":"A web-based nomogram predicting para-aortic nodal metastasis in incompletely staged patients with endometrial cancer: A Korean Multicenter Study","volume":"24","author":"Kang","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2016.04.005_bib48","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ijrobp.2014.11.022","article-title":"Nomograms for\u00a0prediction of outcome with or without adjuvant radiation therapy\u00a0for patients with endometrial cancer: A pooled analysis of PORTEC-1 and PORTEC-2 trials","volume":"91","author":"Creutzberg","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib49","article-title":"Nomogram to predict risk of lymph node metastases in patients with endometrioid endometrial cancer","author":"Pollom","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.brachy.2016.04.005_bib50","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1245\/s10434-015-4548-6","article-title":"A predictive model using histopathologic characteristics of early-stage type 1 endometrial cancer to identify patients at high risk for lymph node metastasis","volume":"22","author":"Bendifallah","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ygyno.2006.02.007","article-title":"Final analysis of RTOG 9708: Adjuvant postoperative irradiation combined with cisplatin\/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer","volume":"103","author":"Greven","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib52","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.ejca.2010.06.002","article-title":"Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer\u2013results\u00a0from two randomised studies","volume":"46","author":"Hogberg","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.brachy.2016.04.005_bib53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/IGC.0000000000000561","article-title":"The impact of adjuvant therapy on survival and recurrence patterns in women with early-stage uterine carcinosarcoma: A multi-institutional study","volume":"26","author":"Guttmann","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2016.04.005_bib54","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.brachy.2015.02.194","article-title":"Vaginal brachytherapy for early-stage carcinosarcoma of the uterus","volume":"14","author":"Brown","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.04.005_bib55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0360-3016(97)00581-6","article-title":"Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy","volume":"40","author":"Turner","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ygyno.2005.01.001","article-title":"Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma","volume":"97","author":"Low","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib57","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ygyno.2012.07.112","article-title":"Five-year outcomes of adjuvant carboplatin\/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer","volume":"127","author":"Kiess","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib58","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijrobp.2012.03.011","article-title":"The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer","volume":"85","author":"Barney","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib59","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ygyno.2012.12.026","article-title":"Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial cancer","volume":"129","author":"Townamchai","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib60","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/gyno.2000.5737","article-title":"The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma","volume":"77","author":"Cirisano","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib61","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/IGC.0b013e318229264e","article-title":"Survival of Danish patients with endometrial cancer in the intermediate-risk group not given postoperative radiotherapy: The Danish Endometrial Cancer Study (DEMCA)","volume":"21","author":"Bertelsen","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2016.04.005_bib62","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ygyno.2012.12.021","article-title":"Pelvic insufficiency fractures in patients with cervical and endometrial cancer treated with postoperative pelvic radiation","volume":"128","author":"Shih","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib63","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ijrobp.2006.09.004","article-title":"Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma","volume":"67","author":"Fayed","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib64","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.ejca.2011.11.014","article-title":"Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data","volume":"48","author":"Nout","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.brachy.2016.04.005_bib65","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0360-3016(93)90455-5","article-title":"Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma","volume":"27","author":"Bruner","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib66","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ygyno.2008.12.039","article-title":"Second neoplasms in survivors of endometrial cancer: Impact of radiation therapy","volume":"113","author":"Kumar","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib67","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/bju.12543","article-title":"Bladder cancer incidence and mortality in patients treated with radiation for uterine cancer","volume":"114","author":"Baack Kukreja","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.brachy.2016.04.005_bib68","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1200\/JCO.2014.58.6693","article-title":"No increased risk of second cancer after radiotherapy in patients treated for rectal or endometrial cancer in the randomized TME, PORTEC-1, and PORTEC-2 trials","volume":"33","author":"Wiltink","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib69","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijrobp.2009.07.1692","article-title":"A population-based study of subsequent primary malignancies after endometrial cancer: Genetic, environmental, and treatment-related associations","volume":"78","author":"Brown","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib70","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ygyno.2012.07.111","article-title":"A novel low dose fractionation regimen for adjuvant vaginal brachytherapy in early stage endometrioid endometrial cancer","volume":"127","author":"Townamchai","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib71","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ijrobp.2010.10.071","article-title":"Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer","volume":"82","author":"Bahng","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib72","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.brachy.2015.03.001","article-title":"Predictors of vaginal stenosis after intravaginal high-dose-rate brachytherapy for endometrial carcinoma","volume":"14","author":"Park","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.04.005_bib73","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brachy.2015.09.012","article-title":"Vaginal brachytherapy for postoperative endometrial cancer: 2014 survey of the American Brachytherapy Society","volume":"15","author":"Harkenrider","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.04.005_bib74","unstructured":"PORTEC 4. Available at: https:\/\/www.maastro.nl\/en\/5\/428\/portec-4.aspx. Accessed March 18,\u00a02015."},{"key":"10.1016\/j.brachy.2016.04.005_bib75","unstructured":"Personal Communication with Creutzberg CL on 29 December\u00a02015."},{"key":"10.1016\/j.brachy.2016.04.005_bib76","first-page":"1749","article-title":"Measurement of vaginal length: Reliability of the vaginal sound\u2013a Gynecologic Oncology Group Study","volume":"16","author":"Bruner","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2016.04.005_bib77","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/j.ijrobp.2012.03.030","article-title":"Sexual functioning among endometrial cancer patients treated with adjuvant high-dose-rate intra-vaginal radiation therapy","volume":"84","author":"Damast","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib78","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1245\/s10434-014-3562-4","article-title":"Comparative patient-centered outcomes (health state and adverse sexual symptoms) between adjuvant brachytherapy versus no adjuvant brachytherapy in early stage endometrial cancer","volume":"21","author":"Damast","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib79","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.radonc.2015.06.018","article-title":"Prospective study of vaginal dilator use adherence and efficacy following radiotherapy","volume":"116","author":"Law","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib80","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ijrobp.2015.02.029","article-title":"Dosimetric predictors of radiation-induced vaginal stenosis after pelvic radiation therapy for rectal and anal cancer","volume":"92","author":"Son","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib81","first-page":"CD007291","article-title":"Vaginal dilator therapy for women receiving pelvic radiotherapy","author":"Miles","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.brachy.2016.04.005_bib82","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1089\/jwh.2008.1281","article-title":"Vaginal estrogen therapy for the treatment of atrophic vaginitis","volume":"18","author":"Lynch","year":"2009","journal-title":"J Womens Health (larchmt)"},{"key":"10.1016\/j.brachy.2016.04.005_bib83","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9378(65)80004-7","article-title":"The effect of topical estrogen on irradiated vaginal epithelium","volume":"92","author":"Pitkin","year":"1965","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.brachy.2016.04.005_bib84","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1148\/99.2.417","article-title":"Postirradiation vaginitis. An evaluation\u00a0of prophylaxis with topical estrogen","volume":"99","author":"Pitkin","year":"1971","journal-title":"Radiology"},{"key":"10.1016\/j.brachy.2016.04.005_bib85","first-page":"215","article-title":"Vaginal administration\u00a0of low-dose conjugated estrogens: Systemic absorption and effects on the endometrium","volume":"84","author":"Handa","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.brachy.2016.04.005_bib86","first-page":"CD001500","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women","author":"Suckling","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.brachy.2016.04.005_bib87","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ejca.2014.03.006","article-title":"Effects of hormone replacement therapy on the rate of recurrence in endometrial cancer survivors: A meta-analysis","volume":"50","author":"Shim","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.brachy.2016.04.005_bib88","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.brachy.2005.02.002","article-title":"Vaginal lymphatic channel location and its implication for intracavitary brachytherapy radiation treatment","volume":"4","author":"Choo","year":"2005","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.04.005_bib89","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.brachy.2007.02.042","article-title":"Vaginal cuff brachytherapy for endometrial carcinoma: Results of limiting vaginal coverage to one centimeter length","volume":"6","author":"Owens","year":"2007","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.04.005_bib90","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brachy.2011.08.005","article-title":"American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy","volume":"11","author":"Small","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.04.005_bib91","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.ijrobp.2005.04.038","article-title":"American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: Current status of vaginal brachytherapy","volume":"63","author":"Small","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib92","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0360-3016(98)00194-1","article-title":"Cost minimization analysis of high-dose-rate versus low-dose-rate brachytherapy in endometrial cancer. Gynecology Tumor Group","volume":"42","author":"Pinilla","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib93","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S1538-4721(02)00051-X","article-title":"Postoperative intravaginal brachytherapy for endometrial cancer; dosimetric analysis of vaginal colpostats and cylinder applicators","volume":"1","author":"Kim","year":"2002","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.04.005_bib94","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0360-3016(98)00453-2","article-title":"The use and advantages of a multichannel vaginal cylinder in high-dose-rate brachytherapy","volume":"44","author":"Demanes","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib95","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.radonc.2003.11.006","article-title":"Multi-channel intracavitary vaginal brachytherapy using three-dimensional optimization of source geometry","volume":"70","author":"Tanderup","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib96","first-page":"362","article-title":"Single versus multichannel applicator in high-dose-rate vaginal brachytherapy optimized by inverse treatment planning","volume":"6","author":"Bahadur","year":"2015","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2016.04.005_bib97","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.brachy.2015.08.009","article-title":"Multichannel vaginal cylinder brachytherapy-impact of tumor thickness and location on dose to organs at risk","volume":"14","author":"Glaser","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.04.005_bib98","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.brachy.2014.10.002","article-title":"Postoperative brachytherapy for endometrial cancer using a ring applicator","volume":"14","author":"Vanneste","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.04.005_bib99","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.brachy.2014.07.007","article-title":"Adjuvant brachytherapy for endometrial cancer: Advantages of the vaginal mold technique","volume":"14","author":"El Khoury","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.04.005_bib100","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ygyno.2009.10.044","article-title":"A new method of anatomically conformal vaginal cuff HDR brachytherapy","volume":"116","author":"Miller","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib101","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.brachy.2011.12.009","article-title":"Is there any advantage to three-dimensional planning for vaginal cuff brachytherapy?","volume":"11","author":"Kim","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.04.005_bib102","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.prro.2012.10.002","article-title":"Dosimetric and cost comparison of first fraction imaging versus fractional re-imaging on critical organ dose in vaginal cuff brachytherapy","volume":"3","author":"Corso","year":"2013","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib103","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.prro.2012.12.005","article-title":"Single or multi-channel vaginal cuff high-dose-rate brachytherapy: Is replanning necessary prior to each fraction?","volume":"4","author":"Zhou","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib104","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.brachy.2010.10.005","article-title":"Should the organs at risk be contoured in vaginal cuff brachytherapy?","volume":"10","author":"Holloway","year":"2011","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.04.005_bib105","doi-asserted-by":"crossref","first-page":"20120428","DOI":"10.1259\/bjr.20120428","article-title":"Vaginal vault brachytherapy in endometrial cancer: Verifying target coverage with image-guided applicator placement","volume":"86","author":"Humphrey","year":"2013","journal-title":"Br J Radiol"},{"key":"10.1016\/j.brachy.2016.04.005_bib106","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.ijrobp.2006.10.041","article-title":"Effects of prescription depth, cylinder size, treatment length, tip space, and curved end on doses in high-dose-rate vaginal brachytherapy","volume":"67","author":"Li","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib107","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ijrobp.2008.01.041","article-title":"Prospective clinical trial of bladder filling and three-dimensional dosimetry in high-dose-rate vaginal cuff brachytherapy","volume":"72","author":"Stewart","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib108","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.ijrobp.2011.08.023","article-title":"Image-based 3D treatment planning for vaginal cylinder brachytherapy: Dosimetric effects of bladder filling on organs at risk","volume":"83","author":"Hung","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib109","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.brachy.2015.02.391","article-title":"Dosimetric analysis of rectal filling on rectal doses during vaginal cuff brachytherapy","volume":"14","author":"Sabater","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.04.005_bib110","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1259\/bjr.75.891.750234","article-title":"The influence of applicator angle on dosimetry in vaginal vault brachytherapy","volume":"75","author":"Hoskin","year":"2002","journal-title":"Br J Radiol"},{"key":"10.1016\/j.brachy.2016.04.005_bib111","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0360-3016(00)00689-1","article-title":"The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium","volume":"48","author":"Nag","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.04.005_bib112","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.prro.2014.01.003","article-title":"The role of postoperative radiation therapy for endometrial cancer: Executive summary of an American Society for Radiation Oncology evidence-based guideline","volume":"4","author":"Klopp","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2016.04.005_bib113","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/bjc.2014.322","article-title":"Treatment preferences and involvement in treatment decision making of patients with endometrial cancer and clinicians","volume":"111","author":"Kunneman","year":"2014","journal-title":"Br J Cancer"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472116300496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472116300496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:10:52Z","timestamp":1761531052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472116300496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1538472116300496"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2016.04.005","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2016.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}